Stephanie Seiler serves as Sangamo’s Vice President and Head of Business Development and Alliance Management. She leads all corporate and business development, alliance management, patient advocacy and government relations. Since joining Sangamo in 2021, she has been integral in the engagement of partners across Sangamo’s priority portfolio pipeline.

Prior to joining Sangamo, Stephanie served as the Head of Licensing, Innovation and Strategic Partnerships at MilliporeSigma, the leading supplier to the global Life Science industry, where she led a global team to execute and grow strategic partnership deals with external stakeholders. In her 19-year tenure, she built a strong pipeline of strategic partnership opportunities (in-licensed IP, collaborations, strategic partnerships, OEM/distribution) to achieve aggressive corporate goals.

She received her Bachelor’s degree in Biology and Anthropology from Harvard College and earned a certificate in Disruptive Technologies at Harvard Business School Online.